Policy Maker

AUSTIN, Texas — In the keynote presentation at the National Kidney Foundation Spring Clinical Meetings, Lilia Cervantes, MD, detailed a framework for advocacy in the kidney community and called upon nephrologists to take action.

Fifty years after Congress enacted the End-Stage Renal Disease Program in 1972, the American Society of Nephrology celebrates the milestone in American kidney health.

A new report from the Milken Institute recommends that health officials prioritize identification of the root causes of health inequity that contribute to kidney disease in efforts to slow down its occurrence.

The global burden of hypertension remains high and continues to increase, despite evidence-based therapies that have been in cardiologists’ armamentaria for many years. As a result, new treatment options are being developed and clinicians are contemplating changes to management of patients who have hypertension or are at risk for it.